How much does one dose of lpilimumab cost?

Ipilimumab (Ipilimumab) is a drug that belongs to the class of immune checkpoint inhibitors. It is used to treat some types of malignancies, particularly melanoma, a type of skin cancer.

Ipilimumab is not currently available in China, so patients cannot purchase it domestically and can only purchase it through overseas purchase channels. There are only original drugs of Ipilimumab abroad, mainly Turkish original drugs and Bristol-Myers Squibb original drugs. The price of Turkish original drugs is around 12,000 yuan, and the specification is 50mg/10ml; Bristol-Myers Squibb's original drug costs about 11,700 yuan, and its specifications are also 50mg/10ml. The ingredients of the two drugs are the same.

Ipilimumab’s mechanism of action is to inhibitCTLA-4 (cytotoxicTlymphocyte-associated antigen-4) immune checkpoint molecule. CTLA-4 is a negative regulatory molecule that can inhibit the activity of the immune system and prevent immune cells from attacking tumor cells. By inhibiting CTLA-4, ipilimumab can enhance the immune system's ability to attack tumors and help control tumor growth and spread.

Ipilimumab is often used as a treatment option for cancer, especially melanoma (skin cancer). It may cause some immune-related side effects because it increases immune system activity. These side effects can include skin inflammation, gastrointestinal problems, and immune thyroid disease.

Please note that use of ipilimumab must be under physician supervision as it may not be suitable for all patients and requires careful management to manage potential side effects and monitor treatment effectiveness. Treatment options and dosages will vary based on the patient's specific condition and type of cancer. If you or someone you know is considering ipilimumab treatment, it is recommended to consult with a professional healthcare provider for personalized advice and treatment plan.